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Background: Emergence of drug-resistant strains of Candida and inefficiency of conventional antifungal therapy has
necessitated the search for alternative and new antifungal agents. Inhibition of virulence and biofilm are the potential
drug targets. In this study, the oils of Carum copticum, Thymus vulgaris and their major active compound thymol as
revealed by Gas chromatography and gas chromatography–mass spectrometry (GC-GC/MS) analysis were tested for
their inhibitory activity against growth to determine sub-MIC values against 27 drug-resistant strains of Candida spp.
Methods: Brothmacrodilution method was used for determination of MIC of test oils against Candida strains. The
spectrophotometric methods were used for detection and inhibition assays for virulence factors in Candida spp. Light
and electron microscopy was performed to observe morphological effects of oils on biofilms. GC-GC/MS were used to
evaluate the major active compounds of test oils.
Results: Virulence factors like proteinase and haemolysin were detected in 18 strains, both in solid and liquid media. A
70% of the test strains exhibited hydrophobicity and formed moderate to strong biofilms (OD280 0.5- > 1.0). Test oils
exhibited MICs in the range of 45–360 μg.mL−1 against the majority of test strains. All the oils at 0.25× and 0.5× MICs
induced >70% reduction in the cell surface hydrophobicity, proteinase and haemolysin production. At 0.5× MIC, thymol
and T. vulgaris were most inhibitory against biofilm formation. At sub-MICs electron microscopic studies revealed the
deformity of complex structures of biofilms formed and cell membranes appeared to be the target site of these agents.
Conclusions: Therefore, our findings have highlighted the concentration dependent activity of oils of C. copticum and
T. vulgaris against virulence factors and biofilms in proteinase and haemolysin producing drug-resistant strains of Candida
spp. The above activities of test oils are supposed to be mainly contributed due to their major active compound thymol.
Further mechanism involving anti-proteinase, anti-haemolysin and anti-biofilm activities of these oils and compounds are
to be explored for possible exploitation in combating Candida infections.Background
Candida spp cause infections of immuno-competent
individuals and, are frequently life-threatening, in particular
in immuno-compromised individuals, whose numbers are
constantly increasing due to organ transplant, chemotherapy,
or, AIDS and Hepatitis C [1]. Candida spp now ranks as
fourth most common cause of nosocomial bloodstream
infection in the United States and the attributable mortality* Correspondence: khanmsa@hotmail.com
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unless otherwise stated.rate is 35% [2]. About 70% of women experience vaginal
infections caused by Candida spp and 20% of them
suffered from recurrence [3]. Candida albicans accounts
for the majority of cases with candidiasis, but an increasing
number of infections due to non-albicans spp. have
been reported [4]. The most commonly isolated non-
albicans Candida are C. glabrata (causing 3%-35% of
all candidemias), followed by C. tropicalis, C. parapsilosis,
C. krusei, and other Candida spp [5,6]. Moreover, the
majority of such manifestations of candidiasis are associated
in one way or another with the formation of Candida
biofilms on the surfaces of inert or biological surfaces [7].
Biofilm cells are notoriously resistant to antimicrobial
agents and withstand host immune defenses [8].d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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infections have several problems namely undesirable
side effects, rapid development of drug-resistance and
inefficacy against biofilm forming pathogens [9]. This
scenario has exacerbated the need for alternative antifungal
therapy and search for new and better agents that target
fundamental biological processes and/or pathogenic deter-
minants. It is expected that compounds with anti-virulence
and antibiofilm activities may reduce or interfere with
the production of one or more virulence factors and
tolerance to drugs at lower doses. This will attenuate
pathogenicity of microorganism without producing
killing pressure and therefore development of resistance
could be overcome. Further biofilm inhibition by the
compound will also reduce the persistence and increased
tolerance to drugs.
In the past decade interest in natural products has
increased, and medicinal plants have been investigated for
various biological activities and therapeutic potentials
[10-13]. Oils of Carum copticum and Thymus vulgaris have
been shown to exhibit antifungal activities against patho-
genic isolates of Candida spp [14-21]. However little or no
information is available on anti-infective properties of
these oils at non-growth inhibitory concentrations i.e.
sub-MICs. Therefore, one way to demonstrate these
oils to be effective antipathogenic agents is to check
their ability to arrest the production of extracellular
enzymatic virulence factors in Candida spp that assist
the pathogen to colonize host tissues, cause disease,
and overcome host defenses [22].
Multiple characteristics of C. albicans have been pro-
posed as virulence traits including the phenotypic vari-
ability, germination, adherence to inert and biological
substrates, cell-surface hydrophobicity and production of
secreted hydrolytic enzymes such as aspartyl proteinases,
phospholipases and haemolysin [23-26]. On the other
hand it has been speculated that biofilms account for
as much as 65% of all microbial infections [27]. Since,
ability of a pathogen to form biofilm is intimately
associated with its adhering potential (cell surface
hydrophobicity) and production of virulence factors;
we assumed that essential oils or compounds exhibiting
anti-virulence activity might be effective against Candida
biofilms too.
Therefore, first we attempted to assess the production
of virulence factors (proteinase and haemolysins) and
also cell surface hydrophobicity and biofilm forma-
tion in Candida spp obtained from various clinical
origin. Secondly, sub-MICs of the oils of C. copticum
and T. vulgaris and their major active compound
thymol were determined to evaluate in vitro efficacy
in influencing virulence and biofilm formation by
Candida spp. Fluconazole was used as control drug in
the study.Methods
Organisms and media
In this study, 23 isolates of clinical origin and 4 reference
strains of Candida spp exhibiting varying level of resistance
to antifungal drugs with MIC of fluconazole ranging from
128 to 256 μg.mL−1 [28] were included. The clinical isolates
of C. albicans (CA01-18), C. glabrata (01,02), C. krusei 01
and C. tropicalis (01,02) were isolated from patients with
vaginitis, urinary tract infections and candidemia attending
the Jawaharlal Nehru Medical College and Hospital, Aligarh
Muslim University, Aligarh. All patients gave written
informed consent and the use of these isolates in our study
was approved by the institutional ethics committee of the
Jawaharlal Nehru Medical College and Hospital, Aligarh
Muslim University. Candida albicans NRRLY12983
was kindly provided by the fungal culture collection
at Agricultural Research Service, USDA, Peoria, USA.
The reference strain C. albicans SC5314 exhibiting
production of various virulence factors was provided
by Prof. Rajendra Prasad, Jawaharlal Nehru University,
New Delhi. Strains C. albicans MTCC183 and C. glabrata
MTCC3019 were purchased from the Microbial Type
Culture Collection, Institute of Microbial Technology,
Chandigarh, India. The test strains were maintained
on Sabouraud dextrose agar (SDA) slants at 4°C and
sub-cultured in the Sabouraud dextrose broth (SDB)
prior to use.
Plant essential oils and drugs
Oils of Carum copticum and Thymus vulgaris were
purchased from Aroma Sales Corporation, New Delhi,
India. Whereas, thymol (minimum assay 99%) and drug
powder of fluconazole were purchased from Hi-media
Laboratories, India and Pfizer Co, Mumbai, India, respect-
ively. Stock solutions of fluconazole was prepared in
dimethyl sulphoxide (DMSO) at a concentration of
25 mg.mL−1 and stored at −20°C until used. Essential
oils were diluted ten-fold in 1% DMSO and used in
the assays.
Detection of virulence factors in isolates of Candida spp
Proteinase assay
Production of extracellular proteinase was assessed by
the method of Aoki et al. [29]. using BSA agar plates.
Briefly, 60 mL of a solution containing MgSO4.7H2O
0.04 g, K2HPO4 0.5 g, NaCl 0.2 g, yeast extract 0.2 g,
glucose 4.0 g and BSA (Hi-Media) 0.5 g; was prepared
and the pH was adjusted to 3.5 with 1 N HCL. This
solution was filter sterilized and mixed with 140 ml of
autoclaved melted agar to prepare the BSA agar plates.
Amounts of 10 μL of yeast suspension (1.0 × 106 cfu.mL−1)
were spot inoculated on the BSA agar plates and incubated
at 37°C for 5 days. After incubation, the plates were stained
with 0.1% amido black dye and destained with 15% acetic
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(pZ values) was calculated in terms of the ratio of the diam-
eter of the colony to the total diameter of colony plus zone
of solubilization.
The proteinase production in liquid medium was
determined using the modified method of Kuriyama et al.
[30]. Briefly, 50 ml Erlenmeyer flasks containing 10 ml of
induction medium as described by MacDonald & Odd
[31] was inoculated with 100 μl of Candida cells
(1.0 × 106 cfu ml−1) and incubated at 26°C for 7 days
at 160 rpm. The broth culture was centrifuged at
5000 rpm for 30 min to obtain supernatant. Furthermore,
200 μL of supernatant was mixed with 800 μL of substrate
[1% (w/v) BSA in 0.025 M sodium citrate buffer, pH 3.2]
and incubated at 37°C for 3 h. The reaction was halted by
the addition of 2.0 mL of 5% trichloroacetic acid (TCA)
resulting in precipitation of undigested BSA. Tubes were
kept at ice for 30 min and centrifuged at 2000 g for
20 min. Proteolysis was determined by measuring the
absorbance of soluble peptides at 280nm. A control was
run by mixing substrate to supernatant and immediately
reaction was stopped by adding TCA. The absorbance
value of control was subtracted from test samples to
obtain values for enzyme activity.
Haemolysis assay
Haemolysin production was evaluated using a modified
method of Luo et al. [32]. The blood agar plates were
prepared by adding 7 ml of fresh sheep blood suspended
in sterile phosphate buffer saline (PBS) to 100 mL of
SDA supplemented with 3% (w/v) glucose. Amounts of
10 μl of yeast suspension (1.0 × 106 cfu.mL−1) were spot
inoculated on the blood agar plates and incubated at 37°C
in 5% CO2 for 48 h. After incubation, plates were scored
for the presence of transluscent ring and or a greenish black
halo circumscribing the inoculum growth. Haemolysin
activity (pZ values) was calculated in terms of the ratio of
the diameter of the colony to the total diameter of colony
plus zone of halo.
The haemolysin production in liquid medium was
determined using the method of Manns et al. [33] with
some modifications. The erythrocytes were harvested by
centrifugation of freshly obtained sheep blood for 10 min
at 3000 rpm, and washed three times in PBS. To the pellet,
PBS was added to yield a 10% (v/v) erythrocytes/PBS
suspension. The 10% suspension was then diluted 10
times in PBS. Candida cells were grown in SDB [8%
(w/v) glucose] for 4 days at 37°C. The broth cultures were
centrifuged at 5000 g for 30 min to obtain supernatant.
Furthermore, the culture supernatant and RBC suspension
were mixed in 1:1 ratio and incubated at 37°C for
4 h. Triton X-100 [0.1% (v/v) in PBS] was used as a
positive control whereas 1% DMSO and PBS were used as
negative controls. Tubes were centrifuged at 2000 g for10 min and the absorbances of supernatants were read at
540nm. The percentage of haemolysis was calculated as:
[{(A − B)/(C − B)} × 100]. Where, A and B are the absorb-
ance values of supernatant from the test sample and PBS
(solvent control) respectively and C is the absorbance
value of supernatant from the sample after 100% lysis.
Detection of cell surface hydrophobicity and biofilm
formation in the isolates of Candida spp
Cell surface hydrophobicity
The method of microbial adhesion to hydrocarbons
(MATH) as described by Rosenberg et al. [34] was used
with some modifications to determine the %CSH of
Candida cells. Briefly, Candida cells were grown on
SDA plates amended with 0.5 × and 0.25 ×MICs of test
agents at 25°C for 48 h. Candida cells grown on SDA
plates without amendment of test agents were considered
as untreated control. Yeast suspensions were made in PBS
(A520 of 0.400) and allowed to contact with xylene in 5:1
ratio. The mixtures were vortexed for 1 min at room
temperature and then allowed to separate the two phases
for 10 min. The absorbance of aqueous phase was
read at 520 nm. The %CSH was calculated as follows;
%CSH= [(Ai −Af)/Ai] × 100. Where Ai and Af are the
absorbance values of aqueous yeast suspension at 520 nm
before and after contacting yeast suspension to the
organic phase.
Biofilm formation
The strains were evaluated by 96 well microtiter plates
(HiMedia, Laboratories, Mumbai, India) based XTT
reduction assay for their ability to form biofilms using the
method of Ramage et al. [35] with some modifications.
Briefly, Candida cells were grown in SDB (glucose 8%
[w/v]) at 37°C for 24 h. Cells were harvested and re-
suspended in RPMI 1640 medium with L-glutamine
but without bicarbonate and buffered to pH 7.0 with
MOPS to a cell density of 1.5 × 106 cfu.mL−1. Biofilms
were formed by adding 100 μL of this standardized cell
suspension to wells of microtiter plates and incubating at
37°C for 48 h. After biofilm formation, the medium was
aspirated gently, and non-adherent cells were removed by
washing the biofilms three times with sterile PBS. Further
biofilm formation was analysed by XTT reduction assay.
Briefly, 0.091 mL of XTT (Sigma, N. Delhi) (1 μg.mL−1,
prepared in PBS) and 0.009 mL of menadione (Sigma, N.
Delhi) (1 mmol.L−1, prepared in acetone) was added to
each well and incubated in the dark for 4 h. The colori-
metric change was measured at 492 nm using a Labsystem
Multiskan Ex MTP Reader.
Light microscopy of biofilms formed
Polyvinyl chloride catheter discs (15 mm diameter) were
placed in 6 well tissue culture plates. Wells of the plates
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standardized yeast cell suspension was added to each
well and incubated at 37°C for 48 h. After the formation
of biofilm, medium was discarded and discs were
washed three times with sterile PBS and air dried. The
discs were visualized under bright field light microscope
(Olympus, Japan) at 40 X.
Gas chromatography and gas chromatography–mass
spectrometry analysis of essential oils
The percentage composition of oils and compounds was
determined by GC-FID and the compounds were identified
by GC-MS. GC analysis was carried out on a Shimadzu
2010 Gas Chromatograph equipped with an FID and
25 m× 0.25 mm× 0.25 μm WCOT column coated with
diethylene glycol (AB-Innowax, 7031428, Japan). Injector
temperature was set at 270°C and detector at 280°C.
Nitrogen was used as a carrier gas at a flow rate of
3.0 ml/min at a column pressure of 74.9 kPa. 0.2 μL
of sample were injected into column with a split ratio
of 90.0. The linear temperature program of 60°C to
230°C set at a rate of 3°C min−1 with hold time at
230°C for 10 minutes. The samples were then analyzed on
the same Shimadzu instrument fitted with the same
column and following the same temperature program
as above. MS parameters used were: ionisation voltage
(EI) 70 eV, peak width 2 s, mass range 40–600 amu and
detector voltage 1.5 V. Results were based on GC-FID.
Peak identification was carried out by comparison of the
mass spectra with database of NIST05, NBS75K and
Wiley 8 libraries. Identification of compounds was
confirmed by comparison of their relative retention
indices relative to (C8–C22) n-alkanes with literature
data or authentic compounds [36-38].
Determination of sub-MICs essential oils against
the strains of Candida spp
For MIC determination of essential oils, 10 μL of yeast
suspension (0.5 McFarland) was added to 1 mL SDB
containing serially diluted test oils along with 0.1% (v/v)
Tween 80 and incubated at 37°C for 24 h at 28 ± 2°C.
MIC was defined as the lowest concentration that inhibited
visible growth.
Determination of viability of Candida strains at sub-MICs
of oils
The test strains at a cell density of 1.0 × 106 cfu.mL−1
were inoculated in to test tubes containing 10 ml of SDB
amended with sub-MICs (0.5 × and 0.25 ×MICs) of test
agents for 24 h at 37°C. A control was run without test
agents but containing yeast inoculum at equal cell density.
Viable counts were obtained from the test and control
solutions by plating 100 μL of 10-fold serial dilutions onto
SDA plates and incubating at 37°C for 24 h.Inhibition of virulence factors by essential oils at
sub-MICs
Inhibition of proteinase production
Briefly, 50 ml Erlenmeyer flasks containing10 ml of
induction medium as described by MacDonald and Odds
[31] with and without sub-MICs (0.5 × and 0.25 ×MIC) of
test agents were inoculated with 100 μL of Candida cells
(1.0 × 106 cfu.mL−1) and incubated at 26°C for 7 days at
160 rpm. The inhibition of proteinase production by
oils was determined using the modified method of
Kuriyama et al. [30] as mentioned earlier. The absorbance
value of untreated control was subtracted from treated
samples to obtain values for enzyme activity. Each
experiment was conducted three times with three replicates
per experiment and data are presented as percent reduction
of absorbance values in treated sample over untreated
control.
Inhibition of haemolysin production
Candida cells were grown in SDB [8% (w/v) glucose]
containing 0.5 × and 0.25 ×MIC of test agents for 4 days
at 37°C. The solution without test agents was considered
as untreated control. Further, the inhibition of haemolysin
production by oils was carried out using the method of
Manns et al. [33] with some modifications as mentioned
earlier. Each experiment was conducted three times with
three replicates per experiment and mean absorbance
values were used to calculate the percent reduction of
haemolysin in treated samples over untreated controls.
Inhibition of biofilm formation by essential oils at
sub-MICs
Effect of oils on biofilm formation
The effect of different sub-MICs of oils and drugs (0.5 ×
MIC, 0.25 ×MIC) on the ability of Candida cells to form
biofilm was determined by the modified method of Ramage
et al. [35] with some modifications. Volumes of 0.1 mL of
test agents (2 × final concentrations) in RPMI 1640 medium
was added to each well of microtiter plates. Subsequently,
0.1 mL of standardized yeast cell suspension was added and
plates were incubated at 37°C for 48 h. Antifungal
agent-free wells served as positive controls for biofilm
growth. After incubation, the medium and non-adherent
cells were removed from wells and washed three times
with sterile PBS. Further biofilm formation was analysed
by XTT reduction assay. Absorbance values were used to
measure the inhibition of biofilm formation as follows:
(mean OD492 of treated well/mean OD492 of untreated con-
trol well) × 100.
Scanning electron microscopy of biofilm cells formed in
the presence of oils
For examination by SEM, Candida biofilm cells were
grown on catheter discs in the presence of 0.5 × and
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in the preceding section. Biofilms grown in the absence
of test agents served as control. After washing with PBS,
discs containing biofilms were placed in a fixative solution
of 5% glutaraldehyde in cacodylate buffer in a graded
series of ethanol, immersed in hexamethyldisilazane, and







C. albicans 01 Candidemia KTZ, ICZ, FLZ 41.30 ± 3.75
C. albicans 02 -Do- KTZ, ICZ, FLZ ND
C. albicans 03 -Do- KTZ, ICZ, FLZ 62.11 ± 2.31
C. albicans 04 -Do- KTZ, ICZ, FLZ 61.75 ± 2.85
C. albicans 05 Urine AMB, KTZ, ICZ, FLZ 59.78 ± 4.31
C. albicans 06 -Do- AMB, KTZ, ICZ, FLZ 55.43 ± 3.38
C. albicans 07 -Do- AMB, KTZ, ICZ, FLZ 66.21 ± 2.97
C. albicans 08 -Do- KTZ, ICZ, FLZ ND
C. albicans 09 -Do- AMB, KTZ, ICZ, FLZ 55.10 ± 2.75
C. albicans 10 Vaginitis AMB, KTZ, ICZ, FLZ ND
C. albicans 11 -Do- AMB, KTZ, ICZ, FLZ ND
C. albicans 12 -Do- AMB, KTZ, ICZ, FLZ ND
C. albicans 13 -Do- AMB, KTZ, ICZ, FLZ 25.78 ± 2.98
C. albicans 14 -Do- AMB, KTZ, ICZ, FLZ 33.45 ± 3.71
C. albicans 15 -Do- AMB, KTZ, ICZ, FLZ 44.59 ± 4.97
C. albicans 16 -Do- AMB, KTZ, ICZ, FLZ 24.76 ± 2.38
C. albicans 17 -Do- AMB, KTZ, ICZ, FLZ 40.90 ± 3.36
C. albicans 18 -Do- AMB, KTZ, ICZ, FLZ 53.45 ± 4.97
C. albicans NRRLY12983 Reference strain KTZ, ICZ, FLZ 25.78 ± .17
C. albicans MTCC183 -Do- KTZ, ICZ, FLZ 35.60 ± 1.76
C. albicans SC5314 -Do- - 63.28 ± 5.18
Non albicans-Candida
C. glabrata 01 Vaginitis KTC, ICZ, FLZ 65.39 ± 6.1
C. glabrata 02 -Do- AMB, KTZ, ICZ, FLZ ND
C. glabrata MTCC3019 Reference strain KTC, ICZ, FLZ ND
C. krusei 01 Vaginitis AMB, KTZ, ICZ, FLZ 41.22 ± 3.38
C. tropicalis 01 Candidemia ICZ, FLZ 62.99 ± 5.10
C. tropicalis 02 Vaginitis ICZ, FLZ ND
pZ = (zone of diameter of colony)/(zone of diameter of colony + zone of solubilizatio
pZ = 1; indicates no activity.
*Biofilm formation was considered as Nil for OD490 < 0.1.
OD490 (0.1-0.5); weak biofilm, OD490 (>0.5-1.0); moderate biofilm, OD490 (>1.0); stron
#Proteinase activity was considered as Nil for OD280 < 0.1.
AMB; amphotericin B, FLZ; fluconazole, ICZ; Itraconazole, KTZ; ketoconazole.
ND; not detected.Transmission electron microscopy of planktonic cells
Structural changes produced by test compounds towards
fungal cell were evaluated using transmission electron
microscopy. Briefly, 10 mL of SDB treated with 0.5 × and
0.25 ×MICs of test agents was inoculated with 100 μL of
cell suspension (0.5 McFarland) and incubated at 37°C





Solid medium Liquid medium




0.49 ± 0.04 0.50 ± 0.04 0.63 ± 0.05 1.23 ± 0.11 41.52
0.05 ± 0.01 0.78 ± 0.04 0.60 ± 0.05 0.45 ± 0.02 29.10
0.59 ± 0.02 0.55 ± 0.03 1.0 ± 0.00 1.35 ± 0.13 ND
1.36 ± 0.66 0.80 ± 0.05 1.0 ± 0.00 0.42 ± 0.04 ND
1.0 ± 0.08 1.0 ± 0.00 0.68 ± 0.05 Nil 74.68
1.15 ± 0.10 0.60 ± 0.04 1.0 ± 0.00 0.95 ± 0.04 ND
0.60 ± 0.03 0.71 ± 0.06 1.0 ± 0.00 0.44 ± 0.03 ND
0.28 ± 0.04 0.52 ± 0.05 1.0 ± 0.00 1.18 ± 0.14 ND
1.12 ± 0.09 0.77 ± 0.04 0.83 ± 0.05 0.85 ± 0.06 25.84
0.05 ± 0.01 0.66 ± 0.05 1.0 ± 0.00 1.37 ± 0.22 ND
0.2650.03 0.75 ± 0.04 0.63 ± 0.04 0.61 ± 0.05 37.33
0.35 ± 0.05 0.71 ± 0.04 1.0 ± 0.00 1.00 ± 0.09 ND
0.67 ± 0.08 0.78 ± 0.05 1.0 ± 0.00 1.15 ± 0.10 ND
0.62 ± 0.05 0.73 ± 0.06 1.0 ± 0.00 1.18 ± 0.10 ND
0.55 ± 0.04 1.0 ± 0.00 1.0 ± 0.00 Nil ND
0.58 ± 0.01 1.0 ± 0.00 0.65 ± 0.05 Nil 83.18
0.78 ± 0.02 1.0 ± 0.00 0.64 ± 0.04 Nil 81.25
1.32 ± 0.07 1.0 ± 0.00 0.68 ± 0.05 Nil 91.45
1.15 ± 0.10 0.50 ± 0.04 0.73 ± 0.06 1.21 ± 0.10 24.32
0.60 ± 0.03 1.0 ± 0.00 0.82 ± 0.06 1.35 ± 0.12 24.93
1.09 ± 0.01 0.58 ± 0.05 0.55 ± 0.06 1.06 ± 0.09 74.45
0.05 ± 0.01 1.0 ± 0.00 1.0 ± 0.00 0.20 ± 0.05 ND
0.04 ± 0.09 1.0 ± 0.00 1.0 ± 0.00 Nil 15.96
0.05 ± 0.09 1.0 ± 0.00 1.0 ± 0.00 Nil ND
0.05 ± 0.01 0.55 ± 0.04 0.61 ± 0.04 Nil 28.95
0.14 ± 0.01 0.56 ± 0.04 0.63 ± 0.05 0.98 ± 0.07 60.42
0.06 ± 0.02 0.65 ± 0.05 0.66 ± 0.05 0.57 ± 0.06 34.27
n or precipitation around the colony).
g biofilms.
Figure 1 Detection of extracellular expression of virulence factors
in the strains of Candida spp in solid media. (A) Proteinase
production in C. albicans 04. (B) Haemolysin production in C. albicans
02. (C) Biofilm formation by C. albicans 04 on catheter discs in 48 h,
under 40 × light microscope (mature biofilms exhibiting dense matrix,
hyphae and embedded yeast cells).
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glutaraldehyde in 0.1 M cacodylate buffer (pH 7.2) for
24 h at room temperature. Post fixation was carried out
in 1% osmium tetroxide in cacodylate buffer. Samples
were dehydrated in acetone and embedded in epon.
Ultra thin sections were stained with 12.5% alcoholic
uranyl acetate and viewed under Morgagni 268D
transmission electron microscope at 80 kv.Statistical analysis
All the experiments were performed three times with
three replicates per experiment and data are expressed
as mean ± standard deviation. Statistical significance of
the differences was determined by the one way ANOVA
test using Minitab (V.11.0 for Windows). Reduction in
%CSH in test strains in the presence of oils was compared
to untreated control by one way ANOVA using Duncan’s
method. Similarly, difference in log cfu/ml of treated sam-
ples (0.5 × and 0.25 ×MICs) was compared to untreated
control. P-values of < 0.05 were considered as statistically
significant.Results
Detection of proteinase and haemolysin production
As presented in Table 1 and Figure 1A,B, among the test
strains of C. albicans 71% were positive for proteinase
production and 52% were for haemolysin production on
solid medium. Among the strains of non-albicans Candida
(NAC) production of proteinase and haemolysin was
recorded in 3 different strains.
Production of proteinase and haemolysin in liquid
medium among the strains of Candida spp is depicted
in Table 1. Production of proteinase was recorded in
75% of the test strains of C. albicans. Seven strains from
different clinical origin and three reference strains exhib-
ited higher proteolytic activity with absorbance values
(>1.0). Haemolysin production was recorded in 52% of
the C. albicans strains. Among the NACs, four test
strains exhibited haemolysin production in the range of
15.96 to 60.42%. All the strains producing protease on
solid medium could also produce in liquid medium except
three strains C. albicans MTCC12983, C. glabrata 01 and
C. tropicalis 02. Similar trend was also observed in the
production of haemolysin on solid and liquid medium.
Table 3 Major active compounds of T. vulgaris as
identified by GC/GC-MS analysis
Peak no. Retention
indices
Compound identified % area
1 936 α-pinene 1.1
3 977 β-pinene 0.5
5 1033 α-limonine 0.5
7 1061 γ-terpinene 26.0
8 1023 α- cimene 21.2
11 1078 Z,6-dimethyl-3,5,7-octriene-olstyrene 0.5
17 1288 thymol 44.7
19 1318 carvacrol 0.9
22 1514 1,4-inden-1-one 0.6
24 1564 3-pentene-2-one 1.1
Table 4 Sensitivity of strains of Candida spp to oils of
C. copticum, T. vulgaris and thymol
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and their ability to form biofilms
As evident from Table 1 76% of the test strains of C.
albicans were positive for CSH (24.76 to 66.21% CSH)
as well as proteinase production (A260 nm 0.45 to 1.61).
Among the NACs three strains were hydrophobic with
%CSH ranging from 41.22 to 65.39.
Out of 18 clinical and three reference strains of C.
albicans, 13 strains formed moderate to strong biofilms.
Three strains produced weak biofilms and two strains could
not form biofilms (Table 1 and Figure 1C). Reference
strains C. albicans NRRLY12983 and C. albicans SC5314
formed strong biofilms with absorbance values of >1.0.
Among the 6 non-albicans Candida, only C. tropicalis
01 formed weak biofilm and others were negative.
Among the test strains, non-hydrophobic strains (viz.
C. albicans 02, 08, 10–12, C. glabrata 02, C. glabrata
MTCC3019 and C. tropicalis 02) were either non-biofilm
or weak biofilm formers.Test strains MIC (μg.mL−1)
C. copticum T. vulgaris Thymol
C. albicans
C. albicans 01 360 180 90
C. albicans 02 180 180 90
C. albicans 03 180 360 90
C. albicans 04 180 360 180
C. albicans 05 180 360 90GC-GC/MS analysis
GC and GC-MS analysis of essential oils revealed the
presence of various major and minor compounds. Main
C. copticum oil components were ρ-cymene (33.67%),
thymol (22.82%) and γ-terpinene (21.61%). Thymol
was the main constituent (44.71%) of T. vulgaris followed
by γ-terpinene (26.01%) and α-cymene (21.22%) (Tables 2
and 3).C. albicans 06 360 360 180
C. albicans 07 360 90 45
C. albicans 08 180 90 45
C. albicans 09 360 180 90
C. albicans 10 360 90 90
C. albicans 11 360 360 90
C. albicans 12 90 180 90
C. albicans 13 360 360 180
C. albicans 14 360 360 180Susceptibility of fungal strains to essential oils and
viability at sub-MICs
As evident from Table 4, test oils exhibited MIC value in
the range of 45–360 μg/ml against one or other strains.
There was no significant (P < 0.05) decrease observed in
log cfu in the test strains of C. albicans at cell density of
1.0 × 106 cfu.mL−1 treated with 0.25 × and 0.5 ×MICs of
test agents compared to untreated control at equal cell
density (Table 5).Table 2 Major active compounds of C. copticum as
identified by GC/GC-MS analysis
Peak no. Retention indices Compound identified % area
1 939 α-pinene 4.5
4 980 β-pinene 12.3
7 992 β-myrcene 2.6
10 1033 α-limonine 0.6
12 1061 γ-terpinene 21.6
13 1017 ρ-cimene 33.8
15 1096 α-dimethyl styrene 0.8
17 1109 limonene o × ide 0.5
22 1288 thymol 22.8
C. albicans 15 360 180 90
C. albicans 16 360 360 90
C. albicans 17 360 90 45
C. albicans 18 180 180 45
C. albicans NRRLY12983 180 180 90
C. albicans MTCC183 180 90 90
C. albicans SC5314 45 90 90
C. glabrata 01 180 360 180
C. glabrata 02 180 360 90
C. glabrata MTCC3019 180 360 90
C. krusei 01 360 360 180
C. tropicalis01 90 360 90
C. tropicalis02 90 360 90
Table 5 Viability assays of strains of Candida spp. e × posed to sub-inhibitory concentrations of oils of C. copticum,
T. vulgaris and thymol
Test agents
(sub-MICs)
Cell viability assay (log cfu.mL−1 at 105 dilution)





Untreated 8.14 ± 0.02 8.04 ± 0.01 8.12 ± 0.03 8.25 ± 0.01 8.02 ± 0.04 8.19 ± 0.01 8.45 ± 0.03 8.07 ± 0.04
Essential oils
C. copticum
0.25 × MIC 7.16 ± 0.04 7.29 ± 0.07 7.34 ± 0.03 7.26 ± 0.04 7.40 ± 0.06 7.38 ± 0.05 7.60 ± 0.02 7.41 ± 0.04
0.5 × MIC 6.10 ± 0.03 6.39 ± 0.05 6.46 ± 0.04 6.24 ± 0.02 6.35 ± 0.03 6.44 ± 0.04 7.17 ± 0.01 6.98 ± 0.05
T. vulgaris
0.25 × MIC 7.09 ± 0.03 7.24 ± 0.06 7.14 ± 0.05 7.19 ± 0.05 7.37 ± 0.04 7.32 ± 0.05 7.71 ± 0.04 7.52 ± 0.02
0.5 × MIC 6.43 ± 0.06 6.41 ± 0.05 6.39 ± 0.07 6.19 ± 0.04 6.27 ± 0.06 6.44 ± 0.07 7.02 ± 0.04 6.71 ± 0.06
Thymol
0.25 × MIC 7.11 ± 0.02 7.16 ± 0.04 7.23 ± 0.06 7.22 ± 0.03 7.24 ± 0.06 7.26 ± 0.05 7.44 ± 0.07 7.29 ± 0.03
0.5 × MIC 6.23 ± 0.04 6.54 ± 0.03 6.44 ± 0.03 6.33 ± 0.06 6.23 ± 0.05 6.33 ± 0.05 7.08 ± 0.07 6.45 ± 0.05
Antifungal drug
Fluconazole
0.25 × MIC 7.08 ± 0.03 7.11 ± 0.06 7.23 ± 0.05 7.16 ± 0.05 7.22 ± 0.04 7.31 ± 0.04 7.14 ± 0.06 7.31 ± 0.05
0.5 × MIC 6.18 ± 0.04 6.45 ± 0.06 6.44 ± 0.05 6.27 ± 0.04 6.15 ± 0.06 6.04 ± 0.05 7.23 ± 0.04 6.88 ± 0.06
Within the columns, untreated means followed by treated means are non-significantly different according to Duncan’s multiple range tests (P < 0.05).
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Oils of C. copticum, T. vulgaris and thymol were further
assessed for their anti-virulence activity at sub-MICs
against the strains C. albicans 04, 05, 07, 16, MTCC183,
SC5314 and C. tropicalis 01. These strains were selected
on the basis of being producers of significant amount of




Percent cell surface hydrophobicity
C. albicans 04 C. albicans 07 C.
Untreated control 61.75 ± 3.45a 62.74 ± 4.35 a 33
Essential oils
C. copticum
0.25 × MIC 22.55 ± 2.24b 21.16 ± 2.24b 22
0.5 × MIC 15.00 ± 1.67b,c 17.87 ± 1.24b,c 12
T. vulgaris
0.25 × MIC 51.37 ± 4.45b 33.70 ± 2.34b 30
0.5 × MIC 43.56 ± 3.31b,c 24.91 ± 1.81b,c 17
Thymol
0.25 × MIC 33.17 ± 2.56a 28.00 ± 2.67a 29
0.5 × MIC 21.23 ± 1.78a 25.11 ± 1.67b 16
Antifungal drug
Fluconazole
0.25 × MIC 61.68 ± 4.67a 43.07 ± 3.89b 31
0.5 × MIC 55.93 ± 3.56a 32.35 ± 3.56b,c 30
Within the columns, means values followed by different letters (a, b, c) are significanEffect on cell surface hydrophobicity
As evident from Table 6, CSH in test strains was affected
in varying capacity when treated with sub-MICs of oils. Test
oils at both the 0.5 × and 0.25 ×MICs were significantly
(P < 0.05) effective in reducing the CSH in one or other
strains. Control drug fluconazole at tested concentrations
could not induce significant reduction in CSH.ibitory concentrations of oils of C. copticum, T. vulgaris
albicans MTCC183 C. albicans SC5314 C. tropicalis 01
.80 ± 3.45a 53.28 ± 3.45a 60.97 ± 5.34a
.69 ± 1.91b 25.34 ± 2.43b 17.31 ± 0.82b
.98 ± 1.47c 16.72 ± 1.81c 6.69 ± 0.45c
.37 ± 2.34a 40.27 ± 3.81b 43.25 ± 4.16b
.05 ± 1.23b 20.18 ± 1.67c 36.39 ± 2.43b
.92 ± 2.89a 35.81 ± 2.78a 34.45 ± 2.67a
.64 ± 1.78b 15.89 ± 1.89b 17.89 ± 1.89b
.74 ± 3.78a 46.89 ± 3.89a 51.23 ± 4.78a
.89 ± 3.78a 40.10 ± 3.89b 43.92 ± 3.89b
tly different according to Duncan’s multiple range tests (P < 0.05).




*Percent reduction in proteinase production over untreated control **Percent reduction in haemolysin production over untreated control
C. albicans 04 C. albicans 09 C. albicans
MTCC183
C. albicans SC5314 C. tropicalis 01 C. albicans 05 C. albicans 16 C. albicans MTCC183 C. albicans SC5314 C. tropicalis 01
Essential oils
C. copticum
0.25× MIC 89.23 ± 4.56 80.74 ± 3.45 88.50 ± 2.34 70.48 ± 4.56 63.67 ± 2.34 53.90 ± 3.45 74.70 ± 4.56 56.89 ± 2.34 56.89 ± 3.45 58.90 ± 3.67
0.5× MIC 94.80 ± 3.56 84.59 ± 5.67 90.91 ± 5.78 82.45 ± 4.56 82.50 ± 3.45 64.13 ± 4.56 87.83 ± 5.67 77.56 ± 3.33 65.78 ± 3.45 70.89 ± 4.56
T. vulgaris
0.25× MIC 92.54 ± 5.67 86.31 ± 5.67 71.99 ± 3.67 65.78 ± 5.67 75.05 ± 4.56 55.41 ± 3.45 79.47 ± 3.45 48.11 ± 3.45 50.89 ± 4.56 50.46 ± 4.56
0.5× MIC 96.00 ± 2.34 91.45 ± 5.67 80.55 ± 5.67 74.83 ± 4.56 87.34 ± 2.34 71.05 ± 4.56 79.47 ± 4.56 63.16 ± 3.45 59.80 ± 3.45 67.10 ± 3.45
Thymol
0.25× MIC 95.98 ± 5.78 89.31 ± 4.56 91.99 ± 5.67 90.78 ± 5.67 88.99 ± 4.45 65.41 ± 2.34 85.00 ± 3.45 71.11 ± 4.57 68.89 ± 3.56 66.46 ± 4.56
0.5× MIC 97.00 ± 5.56 93.67 ± 5.67 92.65 ± 4.67 87.97 ± 4.56 90.67 ± 3.34 78.05 ± 4.56 89.47 ± 4.56 83.16 ± 4.34 69.80 ± 3.63 77.10 ± 5.61
Antifungal drug
Fluconazole
0.25× MIC 50.32 ± 4.47 50.33 ± 4.47 44.13 ± 3.34 43.39 ± 4.56 41.57 ± 4.56 45.32 ± 3.47 49.33 ± 3.47 38.13 ± 4.34 40.39 ± 4.56 40.57 ± 4.56
0.5× MIC 54.23 ± 5.56 57.47 ± 4.57 56.16 ± 4.47 54.80 ± 4.45 54.10 ± 5.33 51.23 ± 4.56 55.47 ± 3.57 46.16 ± 3.47 49.80 ± 3.45 51.10 ± 3.33
*Absorbance at 280 nm for untreated controls were 0.442 ± 0.009 (C. albicans 04), 0.865 ± 0.003 (C. albicans 09), 1.267 ± 0.006 (C. albicans MTCC183), 1.032 ± 0.043 (C. albicans SC5314), 1.010 ± 0.007 (C. tropicalis 01).
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At both of the tested concentrations, test oils were able to
reduce the production of proteinase by >70% in test strains
(Table 7). Maximum reduction of 96.0% was observed for
T. vulgaris at 0.5 ×MIC against C. albicans 04. The test oils
at 0.5 ×MIC induced >70% reduction in the haemolytic
activity of test strains. A maximum reduction of 87.83% was
recorded for C. copticum at 0.5 ×MIC against C. albicans
16. T. vulgaris at both the tested concentrations induced a
reduction of 79.47% against this strain (Table 7).
Inhibition of biofilms
As presented in Table 8, varying level of attenuation in the
biofilm formation by C. albicans cells was observed in the
presence of essential oils. Biofilm formation in both the test
strains was reduced maximally by thymol. At the treatment
of 0.5 ×MIC and 0.25 ×MIC of this oil, 6.90 to 8.34% for-
mation of biofilm was recorded in test strains. Whereas flu-
conazole at 0.5 ×MIC led to 48.16% formation of biofilm in
C. albicans 04. Similar pattern of biofilm formation was also
recorded for test oils and drugs against C. albicans SC5314.
Scanning electron microscopy of sessile cells
Untreated cells resulted in intact biofilm formation with
dense matrix and multilayered network of yeast cells
and hyphae leading to a compact three dimensional
structure (Figure 2A). The treated cells (90 μg ml−1 of C.
copticum) exhibited loosening of cells and disappearance
of matrix. Filamentation is inhibited and destruction of
cell membrane in biofilm was observed (Figure 2B,C).
Untreated sessile cells showed smooth cell membrane
(Figure 2a. inset) whereas treatment with oils exhibited
shrinkage and lysis in cell membranes of sessile cells
(Figure 2b. inset and c. inset). Similar effects were also
observed for thymol (Figure 2D, and d. inset).
Transmission electron microscopy of planktonic cells
In untreated sample of Candida cells, organelles such
as nuclei, mitochondria and nucleus are appeared toTable 8 Effects of oils of C. copticum, T. vulgaris and
thymol on biofilm formation in drug-resistant and
-sensitive strains of C. albicans
Test agents Biofilm formation
C. albicans 04 C. albicans SC5314
0.5 ×MIC 0.25 ×MIC 0.5 ×MIC 0.25 ×MIC
Essential oils
C. copticum 25.32 ± 2.68 40.08 ± 3.69 28.50 ± 2.41 42.92 ± 2.48
T. vulgaris 07.49 ± 0.98 11.70 ± 1.91 14.72 ± 1.05 25.04 ± 2.54
Thymol 07.59 ± 1.69 08.34 ± 1.93 06.90 ± 1.34 07.85 ± 1.18
Antifungal drug
Fluconazole 48.16 ± 0.97 67.61 ± 1.39 48.63 ± 2.24 65.34 ± 3.32be normal (Figure 3A). Treated sample exhibited several
changes including thickening of cell wall, stretching of cell
membrane, leakage of cell wall and cell membrane,
deposition of lipid globules, excessive vacuolization
and abnormal distribution of polysaccharides leading
to deterioration of cytoplasmic contents (Figure 3B-F).
Discussion
Efficient treatment for fungal infections has become very
important as the frequency of life-threatening fungal
diseases is increasing due to the progress in the treatment
of critically ill patients whose immune status has been
deteriorated. Furthermore, high doses drug toxicity and
emergence of drug-resistant strains have added extra
burden for currently available antifungal therapy. Therefore,
development of novel antifungal agents or strategies that
are effective against pathogens that are resistant to
currently available antifungal drugs is of paramount
importance. Considering this, we attempted to investigate
concentration dependent effect of two essential oils namely
C. copticum and T. vulgaris and their major active com-
pound thymol against growth and virulence factors produc-
tion viz. proteinase and haemolysin and biofilm formation
in the drug-resistant strains of Candida spp.
Our data has highlighted the production of proteinase
and haemolysin in the test strains of Candida spp irre-
spective of their source of clinical conditions. Productions
of these virulence factors are in agreement of reports of
other workers [39-41]. Furthermore, hydrophobicity seems
to be associated with biofilms forming ability of the strains.
This could be a very serious threat for removal of infec-
tions caused by drug-resistant strains especially by conven-
tional antifungal drugs such as amphotericin B and azoles
because of their limitations due to host toxicity and drug-
resistance [9]. These test oils were found to be non-toxic at
sub-MICs. Thymol was the major active ingredient of both
the test oils as revealed by GC/GC-MS analysis and found
to be in agreement with the literature [16,19,20]. Moreover,
thymol was found to be more effective in all the inhibitory
assays. This indicates that inhibitory activity of the oils of
C. copticum and T. vulgaris is largely due to the thymol.
However, minor constituents may also play a key role in
the biological activities of these oils.
In this study, all the oils at tested sub-MICs significantly
reduced the CSH in test strains. Hydrophobic cells are
more adherent and resistant to phagocytosis and, therefore
more virulent than hydrophilic cells. In this regard,
lowering of CSH by test oils suggests their importance in
arresting the candidal colonization in pathogenesis.
Furthermore, our findings have revealed strong inhibition
of proteolytic activity by test oils at 0.25 × and 0.5 ×MICs.
Secreted aspartyl proteinases (SAPs) degrade many lesion
proteins at lesion sites, such as albumin, hemoglobin,
keratin, and secretory immunoglobulins A [42]. These
A B
C D
Figure 2 Scanning electron micrograph of the 48 h biofilm formed in C. albicans 04 on catheter discs in the absence and presence of
sub-MICs of oils. (A) Biofilm formed without oils (a. inset) arrow indicates smooth cell membrane of normal cell. (B) Biofilm formed in the
presence of C. copticum at 90 μg.mL−1 (b. inset) bursting of cells leading to vesicle formation due to lytic material (ii). (C) Biofilm formed in the
presence of T. vulgaris at 90 μg.mL−1 (c. inset) cell membrane shrinkage in sessile cells (iii), empty cells (iv). (D) Biofilm formed in the presence of
thymol at 90 μg.mL−1 (d. inset) lysis of membrane and release of cellular material (v).
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virulence of Candida spp. Therefore, inhibition of
extracellular production of proteinase will weaken the
colonization of Candida cells and will be easily evaded by
immune cells. Also, test oils effectively inhibited the
haemolysin production at 0.25 ×MIC. In our knowledge,
there is no report on inhibition of haemolysin production
in C. albicans by essential oils. There are reports that high
concentrations of azole drugs cause an increased Sap
activity in resistant isolates [43]. AMB-resistant strain
developed from C. albicans ATCC10231 exhibited enhanced
activity of virulence factors like extracellular secreted aspartyl
proteinase [44]. In this perspective, oils of C. copticum, T.
vulgaris and thymol exhibiting anti-virulence activity along
with conventional antifungal drugs will be of great advantagein controlling the increase in virulence of drug-resistant
strains. Drug-resistant strains exhibiting production of
virulence factors will be more serious in case of immuno-
compromised patients where relapses of infection occurs
because high doses can not be given and weakened
immune system could not clear the infection. The use of
anti-virulence agent at lower doses of sub-inhibitory
concentration will assist in combating such problems.
Furthermore, our data showed that 77% of C. albicans
strains were strong biofilm formers. This may reflect
similarities in the ability of strains of C. albicans from
different sites of infection to form biofilms and strengthen
the reports from other workers that most of the Candida
infections are associated with biofilm forming ability of
Candida spp. We evaluated oils of C. copticum,T. vulgaris
Figure 3 Transmission electron micrograph of the 48 h grown C. albicans 04 cells in the absence and presence of sub-MICs of oils.
(A) Untreated; intact cell wall, cell membranes and other organelles. (B, C) Cells grown in the presence of C. copticum at 90 μg.mL−1; loosening
of cell membrane (1), disorganized cytoplasm (2), deposition of lipid globules (3), excessive vacuolization (4). (D,E) Cells grown in the presence of
T. vulgaris at 90 μg.mL−1; disorganized protoplasm with receding of cell membrane (5), thickening of cell wall (6). (F) Cells grown in the presence
of thymol at 90 μg.mL−1; lysis of cell wall and shrinkage of cell (7).
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mation of biofilms. If an agent is added at the beginning
of the experiment, the agent might act before the biofilm
formed and inhibit development of biofilm; it could be of
greater interest in combating recalcitrant infections of
Candida biofilms. Our data revealed varying level of
attenuation of biofilm formation by planktonic Candidacells in the presence of test oils and drugs in a dose
dependent manner. Among the tested agents, thymol
showed most inhibitory effect on biofilm formation at
0.5 × and 0.25 ×MIC followed by T. vulgaris and C.
copticum. Control drug fluconazole was less effective
in preventing the formation of biofilms. The concentra-
tion dependent inhibition of biofilm formation was
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albicans 04. In our study, SEM observations have revealed
intact biofilm formation by untreated cells in 48 h whereas
treated cells exhibited disorganization of biofilm stages.
This is appeared to be because of interference of oils with
cell membrane integrity as evidenced by shrinkage of cell
surface and lysis of sessile cells. Similar observations were
reported by Braga et al. [45] for thymol and eugenol
against planktonic cells of C. albicans. This indicates that
Candida cells in both the planktonic and biofilm stages
are affected in a similar fashion and cells in biofilm stage
can not gain increased tolerance to test oils as it attains
against conventional antifuingal drugs. TEM observations
of treated Candida cells indicate that mode of action of
such compounds are disrupting the overall intracellular
endomembranous system. Therefore, it appears that cell
wall and cell membrane integrity, along with other
membranous structures are the target sites of these
compounds. The hydrophobic and volatile nature of
oils may result in their increased uptake through
charged polysaccharides of extracellular matrix of biofilms
making more cells in contact to oils and exerting greater
membrane permeation into Candida cells. This may result
in an increased spectrum of action of these oils on sessile
cells including persister cells leading to a retarded or
disorganized development of biofilms.Conclusions
In conclusion, the non-growth inhibitory concentrations
i.e. sub-MICs of oils of C. copticum and T. vulgaris could
influence the production of proteinase and haemolysin
and biofilm formation. These activities appeared to be due
to the presence of thymol in these oils. Inhibition of pro-
duction of proteinase and haemolysin factors and biofilms
by these oils will add to their efficacy as anti-pathogenic
agents. A potential advantage of this approach is that new
antimicrobials aimed at inhibiting virulence rather than
growth may impose weaker selective pressure for the
development of antibiotic resistance relative to current
antibiotics. Novel therapeutics that target virulence rather
than simply in vitro cell growth would both supplement
and add diversity to our current antimicrobial armament-
arium However, pharmacokinetic studies are needed to
ensure the toxicity and anti-pathogenic ability of these oils
under in vivo to establish their therapeutic potential.Competing interests
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